Moberg outlicenses China rights for Kerasal Nail to Menarini

Sweden based Moberg Pharma AB (OMX: MOB) has granted to  Menarini Asia-Pacific, a member of the Menarini Group – a top 40 global pharmaceutical company –  the exclusive rights to market and sell Kerasal Nail™ in China. The companies now intend to seek marketing authorization for the product in the Chinese market.